PMC:7594251 / 89860-90049 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T639","span":{"begin":79,"end":80},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T640","span":{"begin":109,"end":116},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T641","span":{"begin":181,"end":182},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"Twelve compounds (known inhibitors and derived fragments) were developed using a crystal structure of HIF-1α peptide bound to the stable multiprotein complex pVHL-elongin C:elongin B (VCB)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T513","span":{"begin":24,"end":34},"obj":"Chemical"},{"id":"T514","span":{"begin":109,"end":116},"obj":"Chemical"}],"attributes":[{"id":"A513","pred":"chebi_id","subj":"T513","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A514","pred":"chebi_id","subj":"T514","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"Twelve compounds (known inhibitors and derived fragments) were developed using a crystal structure of HIF-1α peptide bound to the stable multiprotein complex pVHL-elongin C:elongin B (VCB)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"938","span":{"begin":102,"end":108},"obj":"Gene"},{"id":"939","span":{"begin":158,"end":162},"obj":"Gene"},{"id":"940","span":{"begin":163,"end":172},"obj":"Gene"},{"id":"941","span":{"begin":173,"end":182},"obj":"Gene"}],"attributes":[{"id":"A938","pred":"tao:has_database_id","subj":"938","obj":"Gene:3091"},{"id":"A939","pred":"tao:has_database_id","subj":"939","obj":"Gene:7428"},{"id":"A940","pred":"tao:has_database_id","subj":"940","obj":"Gene:6921"},{"id":"A941","pred":"tao:has_database_id","subj":"941","obj":"Gene:6923"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Twelve compounds (known inhibitors and derived fragments) were developed using a crystal structure of HIF-1α peptide bound to the stable multiprotein complex pVHL-elongin C:elongin B (VCB)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T582","span":{"begin":0,"end":189},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Twelve compounds (known inhibitors and derived fragments) were developed using a crystal structure of HIF-1α peptide bound to the stable multiprotein complex pVHL-elongin C:elongin B (VCB)."}